66 related articles for article (PubMed ID: 12861044)
21. Erratum for the Research Article: "Mucosal immunity mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches".
Sci Adv; 2022 Feb; 8(6):eabo0538. PubMed ID: 35148190
[No Abstract] [Full Text] [Related]
22. Biosafety study and mechanism comparison on two types of silica with different nanostructures.
Zhang Y; Chen X; Zhao B; Wu H; Yuan L; Zhang H; Dai W; He B; Xing G; Zhang Q; Wang X
Toxicol Res (Camb); 2017 Jul; 6(4):487-498. PubMed ID: 30090517
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms regulating intestinal barrier integrity and its pathological implications.
Chelakkot C; Ghim J; Ryu SH
Exp Mol Med; 2018 Aug; 50(8):1-9. PubMed ID: 30115904
[TBL] [Abstract][Full Text] [Related]
24. Quercetin Improves Barrier Properties in Porcine Small Intestine but Not in Peyer's Patches.
Cornelius V; Droessler L; Amasheh S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338808
[TBL] [Abstract][Full Text] [Related]
25. Adaptive differentiation promotes intestinal villus recovery.
Ohara TE; Colonna M; Stappenbeck TS
Dev Cell; 2022 Jan; 57(2):166-179.e6. PubMed ID: 35016013
[TBL] [Abstract][Full Text] [Related]
26. Claudins: Beyond Tight Junctions in Human IBD and Murine Models.
Čužić S; Antolić M; Ognjenović A; Stupin-Polančec D; Petrinić Grba A; Hrvačić B; Dominis Kramarić M; Musladin S; Požgaj L; Zlatar I; Polančec D; Aralica G; Banić M; Urek M; Mijandrušić Sinčić B; Čubranić A; Glojnarić I; Bosnar M; Eraković Haber V
Front Pharmacol; 2021; 12():682614. PubMed ID: 34867313
[TBL] [Abstract][Full Text] [Related]
27. Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.
Hashimoto Y; Tachibana K; Krug SM; Kunisawa J; Fromm M; Kondoh M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426497
[TBL] [Abstract][Full Text] [Related]
28. Caprate Modulates Intestinal Barrier Function in Porcine Peyer's Patch Follicle-Associated Epithelium.
Radloff J; Cornelius V; Markov AG; Amasheh S
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897851
[TBL] [Abstract][Full Text] [Related]
29. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
Front Immunol; 2018; 9():2320. PubMed ID: 30356722
[No Abstract] [Full Text] [Related]
30. Oral Administration of Recombinant
Bagherpour G; Ghasemi H; Zand B; Zarei N; Roohvand F; Ardakani EM; Azizi M; Khalaj V
Front Microbiol; 2018; 9():723. PubMed ID: 29706942
[No Abstract] [Full Text] [Related]
31. Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay.
Watari A; Kodaka M; Matsuhisa K; Sakamoto Y; Hisaie K; Kawashita N; Takagi T; Yamagishi Y; Suzuki H; Tsujino H; Yagi K; Kondoh M
Sci Rep; 2017 Nov; 7(1):14514. PubMed ID: 29109448
[TBL] [Abstract][Full Text] [Related]
32. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.
Arabshahi S; Nayeri Fasaei B; Derakhshandeh A; Novinrooz A
Bioengineered; 2018 Jan; 9(1):170-177. PubMed ID: 29091543
[TBL] [Abstract][Full Text] [Related]
33. Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.
Hagen SJ
Tissue Barriers; 2017 Apr; 5(2):e1327839. PubMed ID: 28548895
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of Intestinal Barrier Dysfunction in Sepsis.
Yoseph BP; Klingensmith NJ; Liang Z; Breed ER; Burd EM; Mittal R; Dominguez JA; Petrie B; Ford ML; Coopersmith CM
Shock; 2016 Jul; 46(1):52-9. PubMed ID: 27299587
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
Date AA; Hanes J; Ensign LM
J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
[TBL] [Abstract][Full Text] [Related]
36. Claudin-4 undergoes age-dependent change in cellular localization on pig jejunal villous epithelial cells, independent of bacterial colonization.
Pasternak JA; Kent-Dennis C; Van Kessel AG; Wilson HL
Mediators Inflamm; 2015; 2015():263629. PubMed ID: 25948883
[TBL] [Abstract][Full Text] [Related]
37. Enteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine.
Nagatake T; Fujita H; Minato N; Hamazaki Y
PLoS One; 2014; 9(6):e90638. PubMed ID: 24603700
[TBL] [Abstract][Full Text] [Related]
38. Changes of Tight Junction Protein Claudins in Small Intestine and Kidney Tissues of Mice Fed a DDC Diet.
Abiko Y; Kojima T; Murata M; Tsujiwaki M; Takeuchi M; Sawada N; Mori M
J Toxicol Pathol; 2013 Dec; 26(4):433-8. PubMed ID: 24526818
[TBL] [Abstract][Full Text] [Related]
39. Claudins in intestines: Distribution and functional significance in health and diseases.
Lu Z; Ding L; Lu Q; Chen YH
Tissue Barriers; 2013 Jul; 1(3):e24978. PubMed ID: 24478939
[TBL] [Abstract][Full Text] [Related]
40. Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease.
Söderman J; Norén E; Christiansson M; Bragde H; Thiébaut R; Hugot JP; Tysk C; O'Morain CA; Gassull M; Finkel Y; Colombel JF; Lémann M; Almer S
World J Gastroenterol; 2013 Aug; 19(30):4935-43. PubMed ID: 23946598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
